Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Daniel K. Turner III currently holds 594,349 shares of Orexigen Therapeutics, Inc. (OREX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Daniel K. Turner III has been a net seller of OREX stock. They have purchased $1.1M and sold $16.5M worth of shares.
Daniel K. Turner III's most recent insider trade was on Jun 24, 2015, when they sold 590,554 shares at $0.00 per share.
Daniel K. Turner III serves as Executive at Orexigen Therapeutics, Inc. (OREX). They have executed 38 insider transactions totaling $17.7M over their tenure at the company.
Daniel K. Turner III holds the position of Executive at Orexigen Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 19 years and currently hold a stake valued at $0.
Daniel K. Turner III has shown a selling trading pattern, with $1.1M in total purchases and $16.5M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Daniel K. Turner III was on Mar 18, 2010, when they sold $9.6M worth of SOMX shares. This transaction involved 1,500,000 shares at $6.38 per share.
Daniel K. Turner III currently owns 594,349 shares of Orexigen Therapeutics, Inc. (OREX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Daniel K. Turner III's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Daniel K. Turner III has 38 Form 4 filings on record as an insider at Orexigen Therapeutics, Inc..
Set alerts for Daniel K. Turner III and 40,000+ other insiders.